{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:28:34Z","timestamp":1789018114929,"version":"build-2803163510"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T00:00:00Z","timestamp":1429920000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13041-015-0117-y","type":"journal-article","created":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T12:32:43Z","timestamp":1429878763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Characterization of Aldh2 -\/- mice as an age-related model of cognitive impairment and Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"8","author":[{"given":"Yohan","family":"D\u2019Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elharram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Soon-Shiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R David","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,25]]},"reference":[{"key":"117_CR1","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1212\/WNL.45.8.1594","volume":"45","author":"MA Lovell","year":"1995","unstructured":"Lovell MA, Ehmann WD, Butler SM, Markesbery WR. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer\u2019s disease. Neurology. 1995;45:1594\u2013601.","journal-title":"Neurology"},{"key":"117_CR2","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1523\/JNEUROSCI.18-20-08126.1998","volume":"18","author":"K Hensley","year":"1998","unstructured":"Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci. 1998;18:8126\u20132.","journal-title":"J Neurosci"},{"key":"117_CR3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","volume":"60","author":"A Nunomura","year":"2001","unstructured":"Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurology. 2001;60:759\u201367.","journal-title":"J Neuropathol Exp Neurology"},{"key":"117_CR4","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","volume":"21","author":"D Pratic\u00f2","year":"2001","unstructured":"Pratic\u00f2 D, Uryu K, Leight S, Trojanoswki JQ, Lee VM. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci. 2001;21:4183\u20137.","journal-title":"J Neurosci"},{"key":"117_CR5","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.freeradbiomed.2008.03.012","volume":"44","author":"R Resende","year":"2008","unstructured":"Resende R, Moreira PI, Proen\u00e7a T, Deshpande A, Busciglio J, Pereira C, et al. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med. 2008;44:2051\u20137.","journal-title":"Free Radic Biol Med"},{"key":"117_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","volume":"23","author":"WR Markesbery","year":"1997","unstructured":"Markesbery WR. Oxidative stress hypothesis in Alzheimer\u2019s Disease. Free Radic Biol Med. 1997;23:134\u201347.","journal-title":"Free Radic Biol Med"},{"key":"117_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1021\/tx960130e","volume":"10","author":"DA Butterfield","year":"1997","unstructured":"Butterfield DA. \u03b2-Amyloid-associated free radical oxidative stress and neurotoxicity\u202f: Implications for Alzheimer\u2019s disease. Chem Res Toxicol. 1997;10:495\u2013506.","journal-title":"Chem Res Toxicol"},{"key":"117_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tips.2008.09.001","volume":"29","author":"D Pratic\u00f2","year":"2008","unstructured":"Pratic\u00f2 D. Oxidative stress hypothesis in Alzheimer\u2019s disease: a reappraisal. Trends Pharmacol Sci. 2008;29:609\u201315.","journal-title":"Trends Pharmacol Sci"},{"key":"117_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0197-4580(97)00108-5","volume":"18","author":"MA Lovell","year":"1997","unstructured":"Lovell MA, Ehmann WD, Mattson MP, Markesbery WR. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer\u2019s disease. Neurobiol Aging. 1997;18:457\u201361.","journal-title":"Neurobiol Aging"},{"key":"117_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0197-4580(98)00009-8","volume":"19","author":"WR Markesbery","year":"1998","unstructured":"Markesbery WR, Lovell MA. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer\u02bcs disease. Neurobiol Aging. 1998;19:33\u20136.","journal-title":"Neurobiol Aging"},{"key":"117_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/qjmed\/94.9.485","volume":"94","author":"LT McGrath","year":"2001","unstructured":"McGrath LT, McGleenon BM, Brennan S, McColl D, McIlroy S, Passmore AP. Increased oxidative stress in Alzheimer\u2019s disease as assessed with 4-hydroxynonenal but not malondialdehyde. Q J Med. 2001;94:485\u201390.","journal-title":"Q J Med"},{"key":"117_CR12","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1046\/j.1471-4159.1997.68052092.x","volume":"68","author":"LM Sayre","year":"1997","unstructured":"Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer\u2019s disease. J Neurochem. 1997;68:2092\u20137.","journal-title":"J Neurochem"},{"key":"117_CR13","first-page":"437","volume":"150","author":"KS Montine","year":"1997","unstructured":"Montine KS, Olson SJ, Amarnath V, Whetsell WO, Graham DG, Montine TJ. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer\u02bcs disease is associated with inheritance of APOE4. Am J Path. 1997;150:437\u201343.","journal-title":"Am J Path"},{"key":"117_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2220\/biomedres.30.227","volume":"30","author":"M Fukuda","year":"2009","unstructured":"Fukuda M, Kanou F, Shimada N, Sawabe M, Saito Y, Murayama S, et al. Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer\u2019s disease. Biomed Res. 2009;30:227\u201333.","journal-title":"Biomed Res"},{"key":"117_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.brainres.2009.04.009","volume":"1274","author":"TT Reed","year":"2009","unstructured":"Reed TT, Pierce WM, Markesbery WR, Butterfield DA. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD. Brain Res. 2009;1274:66\u201376.","journal-title":"Brain Res"},{"key":"117_CR16","first-page":"924","volume":"2010","author":"DA Butterfield","year":"1801","unstructured":"Butterfield DA, Bader Lange ML, Sultana R. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer\u2019s disease. Biochim Biophys Act. 1801;2010:924\u20139.","journal-title":"Biochim Biophys Act"},{"key":"117_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2009.10.035","volume":"48","author":"DA Butterfield","year":"2010","unstructured":"Butterfield DA, Galvan V, Lange MB, Tang H, Sowell RA, Spilman P, et al. In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP. Free Radic Biol Med. 2010;48:136\u201344.","journal-title":"Free Radic Biol Med"},{"key":"117_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2012.09.027","volume":"62","author":"R Sultana","year":"2013","unstructured":"Sultana R, Perluigi M, Allan BD. Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer Disease brain. Free Radic Biol Med. 2013;62:157\u201369.","journal-title":"Free Radic Biol Med"},{"key":"117_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0022-510X(98)00042-2","volume":"156","author":"Y Ando","year":"1998","unstructured":"Ando Y, Brannstrom T, Uchida K, Nyhlin N, Nasman B, Suhr O, et al. Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid. J Neurol Sci. 1998;156:172\u20136.","journal-title":"J Neurol Sci"},{"key":"117_CR20","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jmb.2008.01.057","volume":"377","author":"L Liu","year":"2008","unstructured":"Liu L, Komatsu H, Murray IVJ, Axelsen PH. Promotion of amyloid beta protein misfolding and fibrillogenesis by a lipid oxidation product. J Mol Biol. 2008;377:1236\u201350.","journal-title":"J Mol Biol"},{"key":"117_CR21","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1021\/bi061853s","volume":"46","author":"SJ Siegel","year":"2008","unstructured":"Siegel SJ, Bieschke J, Powers ET, Kelly JW. The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation. Biochemistry. 2008;46:1503\u201310.","journal-title":"Biochemistry"},{"key":"117_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1474-9726.2012.00817.x","volume":"11","author":"A-R Gwon","year":"2012","unstructured":"Gwon A-R, Park J-S, Arumugam TV, Kwon Y-K, Chan SL, Kim S-H, et al. Oxidative lipid modification of nicastrin enhances amyloidogenic \u03b3-secretase activity in Alzheimer\u2019s disease. Aging Cell. 2012;11:559\u201368.","journal-title":"Aging Cell"},{"key":"117_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1471-4159.2008.05603.x","volume":"107","author":"L Chen","year":"2008","unstructured":"Chen L, Na R, Gu M, Richardson A, Ran Q. Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer\u2019s disease. J Neurochem. 2008;107:197\u2013207.","journal-title":"J Neurochem"},{"key":"117_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1471-4159.2004.02895.x","volume":"92","author":"E Tamagno","year":"2005","unstructured":"Tamagno E, Parola M, Bardini P, Piccini A, Borghi R, Guglielmotto M, et al. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem. 2005;92:628\u201336.","journal-title":"J Neurochem"},{"key":"117_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bbrc.2003.09.003","volume":"310","author":"D-S Wang","year":"2003","unstructured":"Wang D-S, Iwata N, Hama E, Saido TC, Dickson DW. Oxidized neprilysin in aging and Alzheimer\u2019s disease brains. Biochem Biophys Res Commun. 2003;310:236\u201341.","journal-title":"Biochem Biophys Res Commun"},{"key":"117_CR26","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1471-4159.2008.05855.x","volume":"108","author":"R Wang","year":"2009","unstructured":"Wang R, Wang S, Malter JS, Wang D. Effects of HNE-modification induced by A\u03b2 on neprilysin expression and activity in SH-SY5Y cells. J Neurochem. 2009;108:1072\u201382.","journal-title":"J Neurochem"},{"key":"117_CR27","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.freeradbiomed.2010.09.013","volume":"49","author":"JB Owen","year":"2010","unstructured":"Owen JB, Sultana R, Aluise CD, Erickson MA, Price TO, Bu G, et al. Oxidative modification to LDL receptor- related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Abeta accumulation in AD brain. Free Radic Biol Med. 2010;49:1798\u2013803.","journal-title":"Free Radic Biol Med"},{"key":"117_CR28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/jnen\/60.7.686","volume":"60","author":"MJ Picklo","year":"2001","unstructured":"Picklo MJ, Olson SJ, Markesbery WR, Montine TJ. Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. J Neuropath Exp Neurol. 2001;60:686\u201395.","journal-title":"J Neuropath Exp Neurol"},{"key":"117_CR29","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1021\/tx2005184","volume":"25","author":"B Yoval-S\u00e1nchez","year":"2012","unstructured":"Yoval-S\u00e1nchez B, Rodr\u00edguez-Zavala JS. Differences in susceptibility to inactivation of human aldehyde dehydrogenases by lipid peroxidation byproducts. Chem Res Toxicol. 2012;25:722\u20139.","journal-title":"Chem Res Toxicol"},{"key":"117_CR30","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1046\/j.1471-4159.2003.01619.x","volume":"84","author":"I Ohsawa","year":"2003","unstructured":"Ohsawa I, Nishimaki K, Yasuda C, Kamino K, Ohta S. Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells. J Neurochem. 2003;84:1110\u20137.","journal-title":"J Neurochem"},{"key":"117_CR31","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3233\/JAD-2010-1326","volume":"19","author":"TM Michel","year":"2010","unstructured":"Michel TM, Gsell W, K\u00e4sbauer L, Tatschner T, Sheldrick AJ, Neuner I, et al. Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer\u2019s disease: a human postmortem study. J Alzheimers Dis. 2010;19:1295\u2013301.","journal-title":"J Alzheimers Dis"},{"key":"117_CR32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1017\/S0317167100011938","volume":"38","author":"P Hao","year":"2011","unstructured":"Hao P, Chen Y, Wang J. Meta-analysis of aldehyde dehydrogenase 2 gene polymorphism and Alzheimer\u2019s disease in East Asians. Can J Neurolog Sci. 2011;38:500\u20136.","journal-title":"Can J Neurolog Sci"},{"key":"117_CR33","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.1523\/JNEUROSCI.4956-07.2008","volume":"28","author":"I Ohsawa","year":"2008","unstructured":"Ohsawa I, Nishimaki K, Murakami Y, Suzuki Y, Ishikawa M, Ohta S. Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity. J Neurosci. 2008;28:6239\u201349.","journal-title":"J Neurosci"},{"key":"117_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0166-4328(99)00072-8","volume":"105","author":"DC Rogers","year":"1999","unstructured":"Rogers DC, Jones DN, Nelson PR, Jones CM, Quilter CA, Robinson TL, et al. Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res. 1999;105:207\u201317.","journal-title":"Behav Brain Res"},{"key":"117_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tips.2010.12.007","volume":"32","author":"AM Palmer","year":"2011","unstructured":"Palmer AM. Neuroprotective therapeutics for Alzheimer\u2019s disease: progress and prospects. Trends Pharmacol Sci. 2011;32:141\u20137.","journal-title":"Trends Pharmacol Sci"},{"key":"117_CR36","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"117_CR37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-2008-15408","volume":"15","author":"M Pallas","year":"2008","unstructured":"Pallas M, Camins A, Smith MA, Perry G, Lee H, Casadesus G. From aging to Alzheimer\u2019s Disease : Unveiling \u201cThe Switch\u201d with the senescence-accelerated mouse model. J Alzheimer\u2019s Dis. 2008;15:615\u2013024.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"117_CR38","doi-asserted-by":"publisher","first-page":"13835","DOI":"10.1073\/pnas.1201209109","volume":"109","author":"AO Ardiles","year":"2012","unstructured":"Ardiles AO, Tapia-Rojas CC, Mandal M, Alexandre F, Kirkwood A, Inestrosa NC, et al. Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2012;109:13835\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"117_CR39","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1523\/JNEUROSCI.3672-12.2013","volume":"33","author":"RM Cohen","year":"2013","unstructured":"Cohen RM, Rezai-Zadeh K, Weitz TM, Rentsendorj A, Gate D, Spivak I, et al. A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric a\u03b2, and frank neuronal loss. J Neurosci. 2013;33:6245\u201356.","journal-title":"J Neurosci"},{"key":"117_CR40","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1212\/WNL.51.6.1562","volume":"51","author":"MA Lovell","year":"1998","unstructured":"Lovell MA, Xie C, Markesbery WR. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer\u2019s disease. Neurology. 1998;51:1562\u20136.","journal-title":"Neurology"},{"key":"117_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/jnnp.73.2.126","volume":"73","author":"J Lindeboom","year":"2002","unstructured":"Lindeboom J, Schmand B, Tulner L, Walstra G, Jonker C. Visual association test to detect early dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry. 2002;73:126\u201333.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"117_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007;8:101\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"117_CR43","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","volume":"101","author":"DM Walsh","year":"2007","unstructured":"Walsh DM, Selkoe DJ. A beta oligomers - a decade of discovery. J Neurochem. 2007;101:1172\u201384.","journal-title":"J Neurochem"},{"key":"117_CR44","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10571-011-9691-4","volume":"31","author":"KC Wilcox","year":"2011","unstructured":"Wilcox KC, Lacor PN, Pitt J, Klein WL. Abeta oligomer-induced synapse degeneration in Alzheimer\u2019s disease. Cell Mol Neurobiol. 2011;31:939\u201348.","journal-title":"Cell Mol Neurobiol"},{"key":"117_CR45","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","volume":"271","author":"YM Kuo","year":"1996","unstructured":"Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, et al. Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem. 1996;271:4077\u201381.","journal-title":"J Biol Chem"},{"key":"117_CR46","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nm.2460","volume":"17","author":"DJ Selkoe","year":"2011","unstructured":"Selkoe DJ. Resolving controversies on the path to Alzheimer\u2019s therapeutics. Nat Med. 2011;17:1060\u20135.","journal-title":"Nat Med"},{"key":"117_CR47","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.nbd.2009.05.024","volume":"35","author":"JL Tomic","year":"2009","unstructured":"Tomic JL, Pensalfini A, Head E, Glabe CG. Soluble fibrillar oligomer levels are elevated in Alzheimer\u2019s disease brain and correlate with cognitive dysfunction. Neurobiol Dis. 2009;35:352\u20138.","journal-title":"Neurobiol Dis"},{"key":"117_CR48","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3233\/JAD-2010-101008","volume":"22","author":"H Belinson","year":"2010","unstructured":"Belinson H, Kariv-Inbal Z, Kayed R, Masliah E, Michaelson DM. Following activation of the amyloid cascade, apolipoprotein E4 drives the in vivo oligomerization of amyloid-\u03b2 resulting in neurodegeneration. J Alzheimers Dis. 2010;22:959\u201370.","journal-title":"J Alzheimers Dis"},{"key":"117_CR49","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bbrc.2003.09.003","volume":"310","author":"D-S Wang","year":"2003","unstructured":"Wang D-S, Iwata N, Hama E, Saido TC, Dickson DW. Oxidized neprilysin in aging and Alzheimer\u2019s disease brains. Biochem Biophys Res Commun. 2003;310:236\u201341.","journal-title":"Biochem Biophys Res Commun"},{"key":"117_CR50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1471-4159.2007.05072.x","volume":"104","author":"E Tamagno","year":"2008","unstructured":"Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, et al. Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J Neurochem. 2008;104:683\u201395.","journal-title":"J Neurochem"},{"key":"117_CR51","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.neurobiolaging.2008.07.003","volume":"31","author":"DG Jo","year":"2010","unstructured":"Jo DG, Arumugam TV, Woo HN, Park JS, Tang SC, Mughal M, et al. Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer\u2019s disease. Neurobiol Aging. 2010;31:917\u201325.","journal-title":"Neurobiol Aging"},{"key":"117_CR52","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1471-4159.2008.05855.x","volume":"108","author":"R Wang","year":"2009","unstructured":"Wang R, Wang S, Malter JS, Wang DS. Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells. J Neurochem. 2009;108:1072\u201382.","journal-title":"J Neurochem"},{"key":"117_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s004010100423","volume":"103","author":"JC Augustinack","year":"2002","unstructured":"Augustinack JC, Schneider A, Mandelkow EM, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer\u2019s disease. Acta Neuropathol. 2002;103:26\u201335.","journal-title":"Acta Neuropathol"},{"key":"117_CR54","doi-asserted-by":"publisher","first-page":"23331","DOI":"10.1074\/jbc.M113.463984","volume":"288","author":"A Cavallini","year":"2013","unstructured":"Cavallini A, Brewerton S, Bell A, Sargent S, Glover S, Hardy C, et al. An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease. J Biol Chem. 2013;288:23331\u201347.","journal-title":"J Biol Chem"},{"key":"117_CR55","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.freeradbiomed.2004.11.005","volume":"38","author":"Q Liu","year":"2005","unstructured":"Liu Q, Smith MA, Avil\u00e1 J, DeBernardis J, Kansal M, Takeda A, et al. Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. Free Radic Biol Med. 2005;38:746\u201354.","journal-title":"Free Radic Biol Med"},{"key":"117_CR56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","volume":"15","author":"DP Hanger","year":"2009","unstructured":"Hanger DP, Anderton BH, Noble W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med. 2009;15:112\u20139.","journal-title":"Trends Mol Med"},{"key":"117_CR57","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.2353\/ajpath.2008.080434","volume":"173","author":"N Louneva","year":"2008","unstructured":"Louneva N, Cohen JW, Han LY, Talbot K, Wilson RS, Bennett DA, et al. Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer\u2019s disease. Am J Pathol. 2008;173:1488\u201395.","journal-title":"Am J Pathol"},{"key":"117_CR58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0002-9440(10)63317-2","volume":"165","author":"H Guo","year":"2004","unstructured":"Guo H, Albrecht S, Bourdeau M, Petzke T, Bergeron C, LeBlanc AC. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer\u2019s disease. Am J Pathol. 2004;165:523\u201331.","journal-title":"Am J Pathol"},{"key":"117_CR59","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.tins.2011.09.001","volume":"34","author":"RK Graham","year":"2011","unstructured":"Graham RK, Ehrnhoefer DE, Hayden MR. Caspase-6 and neurodegeneration. Trends Neurosci. 2011;34:646\u201356.","journal-title":"Trends Neurosci"},{"key":"117_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12264-012-1057-5","volume":"28","author":"S Snigdha","year":"2012","unstructured":"Snigdha S, Smith ED, Prieto GA, Cotman CW. Caspase-3 activation as a bifurcation point between plasticity and cell death. Neurosci Bull. 2012;28:14\u201324.","journal-title":"Neurosci Bull"},{"key":"117_CR61","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.2353\/ajpath.2007.060974","volume":"170","author":"S Albrecht","year":"2007","unstructured":"Albrecht S, Bourdeau M, Bennett D, Mufson EJ, Bhattacharjee M, LeBlanc AC. Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol. 2007;170:1200\u20139.","journal-title":"Am J Pathol"},{"key":"117_CR62","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1097\/NEN.0b013e3181c1da10","volume":"68","author":"S Albrecht","year":"2009","unstructured":"Albrecht S, Bogdanovic N, Ghetti B, Winblad B, LeBlanc AC. Caspase-6 activation in familial Alzheimer disease brains carrying amyloid precursor protein, presenilin I or presenilin II mutations. J Neuropathol Exp Neurol. 2009;68:1282\u201393.","journal-title":"J Neuropathol Exp Neurol"},{"key":"117_CR63","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/JAD-2010-100948","volume":"22","author":"J Liu","year":"2010","unstructured":"Liu J, Chang L, Roselli F, Almeida OF, Gao X, Wang X, et al. Amyloid-\u03b2 induces caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors. J Alzheimers Dis. 2010;22:541\u201356.","journal-title":"J Alzheimers Dis"},{"key":"117_CR64","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"D Selkoe","year":"2002","unstructured":"Selkoe D. J. Alzheimer\u2019s disease is a synaptic failure. Science. 2002;298:789\u201391.","journal-title":"Science"},{"key":"117_CR65","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-009-0536-x","volume":"118","author":"T Arendt","year":"2009","unstructured":"Arendt T. Synaptic degeneration in Alzheimer\u2019s disease. Acta Neuropathol. 2009;118:167\u201379.","journal-title":"Acta Neuropathol"},{"key":"117_CR66","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.3749894","volume":"234","author":"ME Greenberg","year":"1986","unstructured":"Greenberg ME, Ziff EB, Greene LA. Stimulation of neuronal acetylcholine receptors induces rapid gene transcription. Science. 1986;234:80\u20133.","journal-title":"Science"},{"key":"117_CR67","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/328175a0","volume":"328","author":"MR Montminy","year":"1987","unstructured":"Montminy MR, Bilezikjian LM. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature. 1987;328:175\u20138.","journal-title":"Nature"},{"key":"117_CR68","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.neuro.21.1.127","volume":"21","author":"AJ Silva","year":"1998","unstructured":"Silva AJ, Kogan JH, Frankland PW, Kida S. CREB and memory. Annu Rev Neurosci. 1998;21:127\u201348.","journal-title":"Annu Rev Neurosci"},{"key":"117_CR69","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S0092-8674(00)81816-4","volume":"87","author":"H Bito","year":"1996","unstructured":"Bito H, Deisseroth K, Tsien RW. CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression. Cell. 1996;87:1203\u201314.","journal-title":"Cell"},{"key":"117_CR70","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S0006-8993(99)01220-2","volume":"824","author":"M Yamamoto-Sasaki","year":"1999","unstructured":"Yamamoto-Sasaki M, Ozawa H, Saito T, R\u00f6sler M, Riederer P. Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res. 1999;824:300\u20133.","journal-title":"Brain Res"},{"key":"117_CR71","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1155\/2009\/618619","volume":"27","author":"J Satoh","year":"2009","unstructured":"Satoh J, Tabunoki H, Arima K. Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus. Dis Markers. 2009;27:239\u201352.","journal-title":"Dis Markers"},{"key":"117_CR72","doi-asserted-by":"publisher","first-page":"6887","DOI":"10.1523\/JNEUROSCI.5291-04.2005","volume":"25","author":"D Puzzo","year":"2005","unstructured":"Puzzo D, Vitolo O, Trinchese F, Jacob JP, Palmeri A, Arancio O. Amyloid-beta peptide inhibits activation of the nitric oxide\/cGMP\/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity. J Neurosci. 2005;25:6887\u201397.","journal-title":"J Neurosci"},{"key":"117_CR73","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/j.1471-4159.2007.04869.x","volume":"103","author":"QL Ma","year":"2007","unstructured":"Ma QL, Harris-White ME, Ubeda OJ, Simmons M, Beech W, Lim GP, et al. Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer\u2019s models. J Neurochem. 2007;103:1594\u2013607.","journal-title":"J Neurochem"},{"key":"117_CR74","doi-asserted-by":"publisher","first-page":"34708","DOI":"10.1074\/jbc.M110.150821","volume":"285","author":"Z Zheng","year":"2010","unstructured":"Zheng Z, Sabirzhanov B, Keifer J. Oligomeric amyloid-{beta} inhibits the proteolytic conversion of brain-derived neurotrophic factor (BDNF), AMPA receptor trafficking, and classical conditioning. J Biol Chem. 2010;285:34708\u201317.","journal-title":"J Biol Chem"},{"key":"117_CR75","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1515\/rns.2011.018","volume":"22","author":"CA Saura","year":"2011","unstructured":"Saura CA, Valero J. The role of CREB signaling in Alzheimer\u2019s disease and other cognitive disorders. Rev Neurosci. 2011;22:153\u201369.","journal-title":"Rev Neurosci"},{"issue":"Suppl 3","key":"117_CR76","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1097\/00002093-199912003-00017","volume":"13","author":"RN Kalaria","year":"1999","unstructured":"Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord. 1999;13 Suppl 3:S115\u201323.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"117_CR77","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/alzrt90","volume":"3","author":"DW Shineman","year":"2011","unstructured":"Shineman DW, Basi GS, Bizon JL, Colton CA, Greenberg BD, Hollister BA, et al. Accelerating drug discovery for Alzheimer\u2019s disease: best practices for preclinical animal studies. Alzheimers Res Ther. 2011;3:28.","journal-title":"Alzheimers Res Ther"},{"key":"117_CR78","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(99)02355-7","volume":"354","author":"MM Esiri","year":"1999","unstructured":"Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer\u2019s disease. Lancet. 1999;354:919\u201320.","journal-title":"Lancet"},{"key":"117_CR79","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/j.1532-5415.2007.01378.x","volume":"55","author":"DS Dede","year":"2007","unstructured":"Dede DS, Yavuz B, Yavuz BB, Cankurtaran M, Halil M, Ulger Z, et al. Assessment of endothelial function in Alzheimer\u2019s disease: is Alzheimer\u2019s disease a vascular disease? J Am Geriatr Soc. 2007;55:1613\u20137.","journal-title":"J Am Geriatr Soc"},{"key":"117_CR80","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1073\/pnas.0608251104","volume":"104","author":"N Chow","year":"2007","unstructured":"Chow N, Bell RD, Deane R, Streb JW, Chen J, Brooks A, et al. Serum response factor and myocardin mediate arterial hyper- contractility and cerebral blood flow dysregulation in Alzheimer\u2019s phenotype. Proc Natl Acad Sci U S A. 2007;104:823\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"117_CR81","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0014-5793(00)01710-5","volume":"476","author":"K Kitagawa","year":"2000","unstructured":"Kitagawa K, Kawamoto T, Kunugita N, Tsukiyama T, Okamoto K, Yoshida A, et al. Aldehyde dehydrogenase (ALDH) 2 associates with oxidation of methoxyacetaldehyde; in vitro analysis with liver subcellular fraction derived from human and Aldh2 gene targeting mouse. FEBS Lett. 2000;476:306\u201311.","journal-title":"FEBS Lett"},{"key":"117_CR82","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/00008571-200211000-00006","volume":"12","author":"T Isse","year":"2002","unstructured":"Isse T, Oyama T, Kitagawa K, Matsuno K, Matsumoto A, Yoshida A, et al. Diminished alcohol preference in transgenic mice lacking aldehyde dehydrogenase activity. Pharmacogenetics. 2002;12:621\u20136.","journal-title":"Pharmacogenetics"},{"key":"117_CR83","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.nlm.2005.09.006","volume":"85","author":"D Van Dam","year":"2006","unstructured":"Van Dam D, Lenders G, De Deyn PP. Effect of Morris water maze diameter on visual-spatial learning in different mouse strains. Neurobiol Learn Mem. 2006;85:164\u201372.","journal-title":"Neurobiol Learn Mem"},{"key":"117_CR84","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neurobiolaging.2006.10.021","volume":"29","author":"AR Delpolyi","year":"2006","unstructured":"Delpolyi AR, Fang S, Palop JJ, Yu G, Wang X, Mucke L. Altered navigational strategy use and visuospatial deficits in hAPP transgenic mice. Neurobiol Aging. 2006;29:253\u201366.","journal-title":"Neurobiol Aging"},{"key":"117_CR85","doi-asserted-by":"crossref","unstructured":"Luong TN, Carlisle HJ, Southwell A, Patterson PH. Assessment of Motor Balance and Coordination in Mice using the Balance Beam. J Vis Exp. 2011; e2376.","DOI":"10.3791\/2376"},{"key":"117_CR86","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/sj.npp.1301054","volume":"32","author":"BM Bennett","year":"2007","unstructured":"Bennett BM, Reynolds JN, Prusky GT, Douglas RM, Sutherland RJ, Thatcher GRJ. Cognitive deficits in rats after forebrain cholinergic depletion are reversed by a novel NO mimetic nitrate ester. Neuropsychopharmacology. 2007;32:505\u201313.","journal-title":"Neuropsychopharmacology"},{"key":"117_CR87","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1126\/science.185.4155.953","volume":"185","author":"K Brendel","year":"1974","unstructured":"Brendel K, Meezan E, Carlson EC. Isolated brain microvessels: a purified, metabolically active preparation from bovine cerebral cortex. Science. 1974;185:953\u20135.","journal-title":"Science"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-015-0117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13041-015-0117-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-015-0117-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-015-0117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T15:55:29Z","timestamp":1717862129000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-015-0117-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,25]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["117"],"URL":"https:\/\/doi.org\/10.1186\/s13041-015-0117-y","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,25]]},"assertion":[{"value":"18 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}